2-[cyclohexyl(methyl)amino]-N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methylpropanamide;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-[methyl(oxan-4-yl)amino]butan-2-one;N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-(2-methylpiperidin-1-yl)propanamide;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-[methyl(propan-2-yl)amino]butan-2-one;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-(oxan-4-ylamino)butan-2-one;N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-piperidin-1-ylpropanamide;N-[3-(1-methoxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-(oxan-4-ylamino)propanamide

C119H202N18O24 — CID 161061839

IUPAC2-[cyclohexyl(methyl)amino]-N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methylpropanamide;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-[methyl(oxan-4-yl)amino]butan-2-one;N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-(2-methylpiperidin-1-yl)propanamide;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-[methyl(propan-2-yl)amino]butan-2-one;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-(oxan-4-ylamino)butan-2-one;N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-piperidin-1-ylpropanamide;N-[3-(1-methoxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-(oxan-4-ylamino)propanamide
SMILESCC(C)(CO)c1cc(NC(=O)C(C)(C)N2CCCCC2)on1.CC(C)(NC1CCOCC1)C(=O)Cc1cc(C(C)(C)CO)no1.CC(C)N(C)C(C)(C)C(=O)Cc1cc(C(C)(C)CO)no1.CC1CCCCN1C(C)(C)C(=O)Nc1cc(C(C)(C)CO)no1.CN(C1CCCCC1)C(C)(C)C(=O)Nc1cc(C(C)(C)CO)no1.CN(C1CCOCC1)C(C)(C)C(=O)Cc1cc(C(C)(C)CO)no1.COCC(C)(C)c1cc(NC(=O)C(C)(C)NC2CCOCC2)on1
InChIInChI=1S/C18H31N3O3.C18H30N2O4.C17H29N3O4.C17H29N3O3.C17H28N2O4.C16H27N3O3.C16H28N2O3/c1-17(2,12-22)14-11-15(24-20-14)19-16(23)18(3,4)21(5)13-9-7-6-8-10-13;1-17(2,12-21)15-10-14(24-19-15)11-16(22)18(3,4)20(5)13-6-8-23-9-7-13;1-16(2,11-22-5)13-10-14(24-20-13)18-15(21)17(3,4)19-12-6-8-23-9-7-12;1-12-8-6-7-9-20(12)17(4,5)15(22)18-14-10-13(19-23-14)16(2,3)11-21;1-16(2,11-20)14-9-13(23-19-14)10-15(21)17(3,4)18-12-5-7-22-8-6-12;1-15(2,11-20)12-10-13(22-18-12)17-14(21)16(3,4)19-8-6-5-7-9-19;1-11(2)18(7)16(5,6)14(20)9-12-8-13(17-21-12)15(3,4)10-19/h11,13,22H,6-10,12H2,1-5H3,(H,19,23);10,13,21H,6-9,11-12H2,1-5H3;10,12,19H,6-9,11H2,1-5H3,(H,18,21);10,12,21H,6-9,11H2,1-5H3,(H,18,22);9,12,18,20H,5-8,10-11H2,1-4H3;10,20H,5-9,11H2,1-4H3,(H,17,21);8,11,19H,9-10H2,1-7H3
InChIKeyUDMPROHDQACSKM-UHFFFAOYSA-N
MW2269.03 g/mol
LogP15.42
Rot. Bonds44

About 2-[cyclohexyl(methyl)amino]-N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methylpropanamide;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-[methyl(oxan-4-yl)amino]butan-2-one;N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-(2-methylpiperidin-1-yl)propanamide;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-[methyl(propan-2-yl)amino]butan-2-one;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-(oxan-4-ylamino)butan-2-one;N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-piperidin-1-ylpropanamide;N-[3-(1-methoxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-(oxan-4-ylamino)propanamide

2-[cyclohexyl(methyl)amino]-N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methylpropanamide;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-[methyl(oxan-4-yl)amino]butan-2-one;N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-(2-methylpiperidin-1-yl)propanamide;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-[methyl(propan-2-yl)amino]butan-2-one;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-(oxan-4-ylamino)butan-2-one;N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-piperidin-1-ylpropanamide;N-[3-(1-methoxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-(oxan-4-ylamino)propanamide (PubChem CID 161061839) has the molecular formula C119H202N18O24 and a molecular weight of 2269.03 g/mol. Its IUPAC name is 2-[cyclohexyl(methyl)amino]-N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methylpropanamide;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-[methyl(oxan-4-yl)amino]butan-2-one;N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-(2-methylpiperidin-1-yl)propanamide;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-[methyl(propan-2-yl)amino]butan-2-one;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-(oxan-4-ylamino)butan-2-one;N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-piperidin-1-ylpropanamide;N-[3-(1-methoxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-(oxan-4-ylamino)propanamide.

Molecular Properties

Compound Name2-[cyclohexyl(methyl)amino]-N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methylpropanamide;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-[methyl(oxan-4-yl)amino]butan-2-one;N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-(2-methylpiperidin-1-yl)propanamide;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-[methyl(propan-2-yl)amino]butan-2-one;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-(oxan-4-ylamino)butan-2-one;N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-piperidin-1-ylpropanamide;N-[3-(1-methoxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-(oxan-4-ylamino)propanamide
PubChem CID161061839
Molecular FormulaC119H202N18O24
Molecular Weight2269.03 g/mol
Exact Mass2267.51
IUPAC Name2-[cyclohexyl(methyl)amino]-N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methylpropanamide;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-[methyl(oxan-4-yl)amino]butan-2-one;N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-(2-methylpiperidin-1-yl)propanamide;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-[methyl(propan-2-yl)amino]butan-2-one;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-(oxan-4-ylamino)butan-2-one;N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-piperidin-1-ylpropanamide;N-[3-(1-methoxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-(oxan-4-ylamino)propanamide
SMILESCC(C)(CO)c1cc(NC(=O)C(C)(C)N2CCCCC2)on1.CC(C)(NC1CCOCC1)C(=O)Cc1cc(C(C)(C)CO)no1.CC(C)N(C)C(C)(C)C(=O)Cc1cc(C(C)(C)CO)no1.CC1CCCCN1C(C)(C)C(=O)Nc1cc(C(C)(C)CO)no1.CN(C1CCCCC1)C(C)(C)C(=O)Nc1cc(C(C)(C)CO)no1.CN(C1CCOCC1)C(C)(C)C(=O)Cc1cc(C(C)(C)CO)no1.COCC(C)(C)c1cc(NC(=O)C(C)(C)NC2CCOCC2)on1
InChIInChI=1S/C18H31N3O3.C18H30N2O4.C17H29N3O4.C17H29N3O3.C17H28N2O4.C16H27N3O3.C16H28N2O3/c1-17(2,12-22)14-11-15(24-20-14)19-16(23)18(3,4)21(5)13-9-7-6-8-10-13;1-17(2,12-21)15-10-14(24-19-15)11-16(22)18(3,4)20(5)13-6-8-23-9-7-13;1-16(2,11-22-5)13-10-14(24-20-13)18-15(21)17(3,4)19-12-6-8-23-9-7-12;1-12-8-6-7-9-20(12)17(4,5)15(22)18-14-10-13(19-23-14)16(2,3)11-21;1-16(2,11-20)14-9-13(23-19-14)10-15(21)17(3,4)18-12-5-7-22-8-6-12;1-15(2,11-20)12-10-13(22-18-12)17-14(21)16(3,4)19-8-6-5-7-9-19;1-11(2)18(7)16(5,6)14(20)9-12-8-13(17-21-12)15(3,4)10-19/h11,13,22H,6-10,12H2,1-5H3,(H,19,23);10,13,21H,6-9,11-12H2,1-5H3;10,12,19H,6-9,11H2,1-5H3,(H,18,21);10,12,21H,6-9,11H2,1-5H3,(H,18,22);9,12,18,20H,5-8,10-11H2,1-4H3;10,20H,5-9,11H2,1-4H3,(H,17,21);8,11,19H,9-10H2,1-7H3
InChIKeyUDMPROHDQACSKM-UHFFFAOYSA-N
XLogP15.42
TPSA548.38 Ų
H-Bond Donors12
H-Bond Acceptors38
Rotatable Bonds44
Heavy Atoms161
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002269.03
LogP ≤ 515.42
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1038

Analyze 2-[cyclohexyl(methyl)amino]-N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methylpropanamide;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-[methyl(oxan-4-yl)amino]butan-2-one;N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-(2-methylpiperidin-1-yl)propanamide;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-[methyl(propan-2-yl)amino]butan-2-one;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-(oxan-4-ylamino)butan-2-one;N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-piperidin-1-ylpropanamide;N-[3-(1-methoxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-(oxan-4-ylamino)propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

3-(cyclopentylamino)-1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methylbutan-2-one
CID 58297223
3-[cyclopentyl(methyl)amino]-3-methyl-1-[3-[2-methyl-1-(oxan-2-yloxy)propan-2-yl]-1,2-oxazol-5-yl]butan-2-one
CID 58297266
N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-(piperidin-4-ylamino)propanamide
CID 91421480
3-methyl-3-[methyl-[(3S)-1-methylsulfonylpyrrolidin-3-yl]amino]-1-[3-[2-methyl-1-(oxan-2-yloxy)propan-2-yl]-1,2-oxazol-5-yl]butan-2-one
CID 58297313
2-(azetidin-1-ylsulfonyl)-N-[3-(1-methoxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methylpropanamide
CID 54771952
3-(cyclopropylmethylamino)-1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methylbutan-2-one
CID 58297196
N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-(oxan-4-ylmethylsulfonyl)propanamide
CID 45256132
N-[3-[(Z)-1-hydroxyprop-1-en-2-yl]-1,2-oxazol-5-yl]-2-methyl-2-(2-methylpiperidin-1-yl)propanamide
CID 136617843
N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-[methyl-[[(3R)-1-methylsulfinylpiperidin-3-yl]methyl]amino]propanamide
CID 126515535
2-[1,4-dioxan-2-ylmethyl(methyl)amino]-N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methylpropanamide
CID 70820826
1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-[[(2S)-oxan-2-yl]methylsulfonyl]butan-2-one
CID 58042627
2-[4-(methanesulfinamido)piperidin-1-yl]-2-methyl-N-[3-[2-methyl-1-(oxan-2-yloxy)propan-2-yl]-1,2-oxazol-5-yl]propanamide
CID 70820859

Frequently Asked Questions

What is the IUPAC name of 2-[cyclohexyl(methyl)amino]-N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methylpropanamide;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-[methyl(oxan-4-yl)amino]butan-2-one;N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-(2-methylpiperidin-1-yl)propanamide;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-[methyl(propan-2-yl)amino]butan-2-one;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-(oxan-4-ylamino)butan-2-one;N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-piperidin-1-ylpropanamide;N-[3-(1-methoxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-(oxan-4-ylamino)propanamide?
The IUPAC name of 2-[cyclohexyl(methyl)amino]-N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methylpropanamide;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-[methyl(oxan-4-yl)amino]butan-2-one;N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-(2-methylpiperidin-1-yl)propanamide;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-[methyl(propan-2-yl)amino]butan-2-one;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-(oxan-4-ylamino)butan-2-one;N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-piperidin-1-ylpropanamide;N-[3-(1-methoxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-(oxan-4-ylamino)propanamide (CID 161061839) is 2-[cyclohexyl(methyl)amino]-N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methylpropanamide;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-[methyl(oxan-4-yl)amino]butan-2-one;N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-(2-methylpiperidin-1-yl)propanamide;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-[methyl(propan-2-yl)amino]butan-2-one;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-(oxan-4-ylamino)butan-2-one;N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-piperidin-1-ylpropanamide;N-[3-(1-methoxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-(oxan-4-ylamino)propanamide.
What is the SMILES notation for 2-[cyclohexyl(methyl)amino]-N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methylpropanamide;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-[methyl(oxan-4-yl)amino]butan-2-one;N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-(2-methylpiperidin-1-yl)propanamide;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-[methyl(propan-2-yl)amino]butan-2-one;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-(oxan-4-ylamino)butan-2-one;N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-piperidin-1-ylpropanamide;N-[3-(1-methoxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-(oxan-4-ylamino)propanamide?
The canonical SMILES for 2-[cyclohexyl(methyl)amino]-N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methylpropanamide;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-[methyl(oxan-4-yl)amino]butan-2-one;N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-(2-methylpiperidin-1-yl)propanamide;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-[methyl(propan-2-yl)amino]butan-2-one;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-(oxan-4-ylamino)butan-2-one;N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-piperidin-1-ylpropanamide;N-[3-(1-methoxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-(oxan-4-ylamino)propanamide is CC(C)(CO)c1cc(NC(=O)C(C)(C)N2CCCCC2)on1.CC(C)(NC1CCOCC1)C(=O)Cc1cc(C(C)(C)CO)no1.CC(C)N(C)C(C)(C)C(=O)Cc1cc(C(C)(C)CO)no1.CC1CCCCN1C(C)(C)C(=O)Nc1cc(C(C)(C)CO)no1.CN(C1CCCCC1)C(C)(C)C(=O)Nc1cc(C(C)(C)CO)no1.CN(C1CCOCC1)C(C)(C)C(=O)Cc1cc(C(C)(C)CO)no1.COCC(C)(C)c1cc(NC(=O)C(C)(C)NC2CCOCC2)on1.
What is the InChIKey of 2-[cyclohexyl(methyl)amino]-N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methylpropanamide;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-[methyl(oxan-4-yl)amino]butan-2-one;N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-(2-methylpiperidin-1-yl)propanamide;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-[methyl(propan-2-yl)amino]butan-2-one;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-(oxan-4-ylamino)butan-2-one;N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-piperidin-1-ylpropanamide;N-[3-(1-methoxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-(oxan-4-ylamino)propanamide?
The InChIKey is UDMPROHDQACSKM-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H31N3O3.C18H30N2O4.C17H29N3O4.C17H29N3O3.C17H28N2O4.C16H27N3O3.C16H28N2O3/c1-17(2,12-22)14-11-15(24-20-14)19-16(23)18(3,4)21(5)13-9-7-6-8-10-13;1-17(2,12-21)15-10-14(24-19-15)11-16(22)18(3,4)20(5)13-6-8-23-9-7-13;1-16(2,11-22-5)13-10-14(24-20-13)18-15(21)17(3,4)19-12-6-8-23-9-7-12;1-12-8-6-7-9-20(12)17(4,5)15(22)18-14-10-13(19-23-14)16(2,3)11-21;1-16(2,11-20)14-9-13(23-19-14)10-15(21)17(3,4)18-12-5-7-22-8-6-12;1-15(2,11-20)12-10-13(22-18-12)17-14(21)16(3,4)19-8-6-5-7-9-19;1-11(2)18(7)16(5,6)14(20)9-12-8-13(17-21-12)15(3,4)10-19/h11,13,22H,6-10,12H2,1-5H3,(H,19,23);10,13,21H,6-9,11-12H2,1-5H3;10,12,19H,6-9,11H2,1-5H3,(H,18,21);10,12,21H,6-9,11H2,1-5H3,(H,18,22);9,12,18,20H,5-8,10-11H2,1-4H3;10,20H,5-9,11H2,1-4H3,(H,17,21);8,11,19H,9-10H2,1-7H3.
What are the key properties of 2-[cyclohexyl(methyl)amino]-N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methylpropanamide;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-[methyl(oxan-4-yl)amino]butan-2-one;N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-(2-methylpiperidin-1-yl)propanamide;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-[methyl(propan-2-yl)amino]butan-2-one;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-(oxan-4-ylamino)butan-2-one;N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-piperidin-1-ylpropanamide;N-[3-(1-methoxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-(oxan-4-ylamino)propanamide?
2-[cyclohexyl(methyl)amino]-N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methylpropanamide;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-[methyl(oxan-4-yl)amino]butan-2-one;N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-(2-methylpiperidin-1-yl)propanamide;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-[methyl(propan-2-yl)amino]butan-2-one;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-(oxan-4-ylamino)butan-2-one;N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-piperidin-1-ylpropanamide;N-[3-(1-methoxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-(oxan-4-ylamino)propanamide has a molecular weight of 2269.03 g/mol, XLogP of 15.42, 44 rotatable bonds, 12 hydrogen bond donors, and 38 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[cyclohexyl(methyl)amino]-N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methylpropanamide;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-[methyl(oxan-4-yl)amino]butan-2-one;N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-(2-methylpiperidin-1-yl)propanamide;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-[methyl(propan-2-yl)amino]butan-2-one;1-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-3-methyl-3-(oxan-4-ylamino)butan-2-one;N-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-piperidin-1-ylpropanamide;N-[3-(1-methoxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-2-methyl-2-(oxan-4-ylamino)propanamide is sourced from PubChem (CID 161061839), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).